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Abstract
Background: Experimentalists are overwhelmed by high-throughput data and there is an urgent need to
condense information into simple hypotheses. For example, large amounts of microarray and deep sequencing
data are becoming available, describing a variety of experimental conditions such as gene knockout and
knockdown, the effect of interventions, and the differences between tissues and cell lines.
Results: To address this challenge, we developed a method, implemented as a Cytoscape plugin called
ExprEssence. As input we take a network of interaction, stimulation and/or inhibition links between genes/proteins,
and differential data, such as gene expression data, tracking an intervention or development in time. We condense
the network, highlighting those links across which the largest changes can be observed. Highlighting is based on a
simple formula inspired by the law of mass action. We can interactively modify the threshold for highlighting and
instantaneously visualize results. We applied ExprEssence to three scenarios describing kidney podocyte biology,
pluripotency and ageing: 1) We identify putative processes involved in podocyte (de-)differentiation and validate
one prediction experimentally. 2) We predict and validate the expression level of a transcription factor involved in
pluripotency. 3) Finally, we generate plausible hypotheses on the role of apoptosis, cell cycle deregulation and
DNA repair in ageing data obtained from the hippocampus.
Conclusion: Reducing the size of gene/protein networks to the few links affected by large changes allows to
screen for putative mechanistic relationships among the genes/proteins that are involved in adaptation to different
experimental conditions, yielding important hypotheses, insights and suggestions for new experiments. We note
that we do not focus on the identification of ‘active subnetworks’. Instead we focus on the identification of single
links (which may or may not form subnetworks), and these single links are much easier to validate experimentally
than submodules. ExprEssence is available at http://sourceforge.net/projects/expressence/.
Background
The pace of data generation in the life sciences is stea-
dily increasing. Primary data sets grow in depth and
accuracy, covering more and more aspects of life. In
molecular biology and biomedicine, these include large-
scale measurements of DNA/Histone acetylation,
transcriptional activity, gene expression and protein
abundance (e.g. [1]). Measuring epigenetic patterns
(DNA methylation, DNA/Histone acetylation) on a large
scale has become possible only recently [1,2]. Measuring
transcription is entering a new era with the introduction
of deep (or next-generation, RNA-seq) sequencing [3,4].
Proteomics is becoming possible at unprecedented
depth, covering ever-larger parts of the proteome on a
routine basis [5]. For these primary data, repositories
such as the Gene Expression Omnibus database (GEO
[6]) or ArrayExpress [7] are constantly expanding.
Often, measurements are differential: they are made
for two or more conditions (such as gene knockdown or
knockout [8]), for two or more time points (such as
time series tracking the consequences of some experi-
mental intervention, [9]), or for two or more species
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any medium, provided the original work is properly cited.(such as mouse and human, [10]). Exploiting differential
measurements is one key to cope with the flood of data,
by focusing on the most pronounced differences.
Life scientists also have to handle a deluge of second-
ary data, in the form of papers, reviews and curated
databases. These may be integrated by automated sys-
tems such as STRING [11], or by manual efforts
[12-14]. Exploiting secondary data provides another key
to cope with the flood of primary data, by putting them
into context and focusing on the most pronounced confir-
mations and contradictions to what is known already.
In this paper, we propose to interpret differential data
in the context of knowledge, yielding the ‘essence’ of an
experiment. Differential data may be provided by two
microarrays, and knowledge may be provided by a net-
work describing gene/protein interaction and regulation.
In this case, data tracking gene expression in the course
of an experiment can be used to identify the most pro-
nounced putative mechanisms. They are identified as
those known links between genes/proteins along which
expression changes indicate that there may have been
some regulatory change, such as the startup or shut-
down of an interaction, a stimulation or an inhibition.
ExprEssence highlights these links, and it enables the
user to filter out all links with no or negligible change.
The higher the filter threshold on the amount of change
to be displayed, the fewer links are shown, making it
straightforward to examine the ‘essence’ of the experi-
ment. Network condensations are illustrated by pairs of
figures (original network - condensed network) in the
section on Case Studies. The condensed network con-
tains good candidates for interpreting the experiment in
mechanistic terms, giving rise to the design of new
experiments. However, all inferences are hypotheses
derived from correlations in the experimental data in
the context of the ap r i o r iknowledge encoded in the
network, and it must be kept in mind that correlative
data do not necessarily entail mechanistic causality.
Moreover, the validity of the hypotheses generated by
o u rm e t h o dw i l ld e p e n do nt h ec o v e r a g ea n dc o r r e c t -
ness of the network, and on the accuracy of the experi-
mental data.
Related Work
Starting with the pioneering work of Ideker et al. [15],
there is a plethora of methods that combine network data
with high-throughput data (such as microarrays), in order
to highlight pathways or subnetworks, see the excellent
recent reviews of Minguez & Dopazo [16], Wu et al. [17]
and Yu & Li [18]. Notably, few of these methods are read-
ily available as publicly accessible software packages, plu-
gins or web services (see Table and in [17]). Also, there
does not seem to be a gold standard that can be used for
validation purposes (see, e.g., Tarca et al. [19] for a recent
discussion). Some methods lack validation except for the
example for which they were developed for, while others
are studied for an array of specific examples. In these
cases, strong enrichment in plausible Gene Ontology cate-
gories or detection of known pathways or annotations is
often used to demonstrate utility, as in [19-25]. We found
two articles including a comparison of different subnet-
work identification methods. The first one by Parkkinen
and Kaski [26] introduces variants of the Interaction Com-
ponent Model (ICM) method, comparing them to the ori-
ginal ICM method, to a method based on hidden modular
random fields (HMoF) [27] and to Matisse [28], using
identification of Gene Ontology classes and coverage of
protein complexes for two selected data sets (osmotic
shock response and DNA damage data) to judge one
method over the other. An evaluation of ClustEx [29], jAc-
tiveModules [15], GXNA [21] and a simple approach
based on fold change can be found in [29], taking identifi-
cation of gene sets, pathways and microarray targets
known from the literature and from the Gene Ontology
for comparison.
In general, it is exceedingly difficult to validate the
detection of (sub-) networks or (sub-) pathways: these
are complex entities, and ultimate experimental valida-
tion is impossible because of this complexity: experi-
mentalists are usually limited to investigating only few
components in isolation at any given time. Nevertheless,
we will compare results of our method with results
obtained by jActiveModules, in a separate section follow-
ing the case studies. In contrast, by just highlighting sin-
gle links in networks, we tackle a more primitive task,
but in this case results can be validated directly by
experiment, or by identifying corroborative statements
in the literature. In particular, as can be seen from our
case studies, the single links that we highlight give rise
to predictions about single genes and about single one-
step mechanisms that can be investigated in isolation.
Therefore, we would like to emphasize the direct utility
of our focus on single links and genes, complementing
the (sub-)network centric view that is usually employed;
to the best of our knowledge, the ‘single link and gene’
focus is not employed by other methods combining net-
work and high-throughput (’omics’) data. In fact, we
propose a ‘winning combination’ of ‘network’/’omics’
and ‘classical’ biology, using networks and high-through-
put data to highlight single genes and links that may
then be validated directly by classical molecular biology,
as will be demonstrated in our case studies.
As future work, our formula for link highlighting can,
however, be integrated into current methods for path-
way/subnetwork detection, possibly improving these
considerably. In particular, no such method treats inhi-
bitions and stimulations in a distinct way, as we do. In
particular, we envision that the edge score formula of
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i a n c e ,m a yb er e p l a c e db yo u rf o r m u l a( s e eb e l o w ) ,
emphasizing a different aspect of differential gene
expression: While Guo et al. identify coordinated
changes using their formula, integration of our formula
into their framework would identify subnetworks with
changes that are consistent with an input network of
interactions, stimulations and inhibitions. In any case,
we wish to stress that for the identification of coordi-
nated changes, correlation coefficients are most suitable.
Our approach, however, identifies a different biological
message, namely startups/shutdowns of interactions, sti-
mulations and inhibitions, using an input network that
is informative about biological relationships such as sti-
mulations and inhibitions.
Implementation
ExprEssence is implemented in Java Standard Edition 6.
It is a plugin for Cytoscape [30], an easy-to-install tool
for biological network analysis and visualization. Cytos-
cape is an open source software project and provides
basic features such as network layout and modification.
Cytoscape can be enhanced for analysis purposes by
straightforward installation of plugins.
Input data
ExprEssence analyses are based on a network of genes
and/or proteins, in a format readable by Cytoscape, such
as cys, sif, xgmml or gpml. It may be imported from
databases using web services such as the Pathway Com-
mons Web Service Client or the WikiPathways Web
Service Client [31,32] as a ‘simplified binary model’ (see
Fig. Five in [33]) or it may be downloaded directly from
the web. Usually, it reflects expert-curated interaction/
regulation data concerning a particular signaling path-
way or molecular phenomenon.
The network data must follow a simple specification
defined by two constraints:
a) Each link (edge) must be typed to represent either
an interaction, stimulation or inhibition. It is possi-
ble that all links represent physical interactions, as is
the case in a pure protein-protein interaction net-
work. Stimulations and inhibitions are directional,
whereas interactions can be interpreted to be un-
directional as well as bi-directional.
b) For each gene (node) at least two numerical
values must be given on which a meaningful com-
parison can be based. For example, these may be
expression values, derived from measurements in
two experiments E1 and E2.
By default, for better data interchangeability, ExprEs-
sence recognizes Systems Biology Ontology terms [34],
also included in the activity flow language of the Sys-
tems Biology Graphical Notation (SBGN, [35]), for the
specification of interaction types. Thus, each link (edge)
must include an attribute called Interactiontype,w h o s e
values can be either stimulation (corresponding to
SBO:0000170), inhibition (SBO:0000169) or interaction
(SBO:0000231). In the networks discussed in this article,
a single node is used for a gene and its protein product,
and the exact nature of the links (edges) denoting sti-
mulations, inhibitions and interactions depends on the
evidence underlying the link. For example, a stimulation
may be due to the modification of one protein by
another, but it may also be the transcriptional stimula-
tion of a target gene by a transcription factor.
The differential measurement data used for compari-
son may be integrated into the network as described in
the Cytoscape manual [36]. Usually, integration is
accomplished by mapping unique gene/protein identi-
fiers in the data to unique gene/protein identifiers in the
network. The measurements m a yb eg e n ee x p r e s s i o n
values, but they may also denote protein abundance,
methylation levels, etc.
If the numerical data result from multiple measure-
ments (replicates), the number of replicates has to be
declared for each experiment, and for each experiment
and for each node (gene/protein), the mean value and
its corresponding variance have to be given. More speci-
fically, for two experiments E1 and E2 to be compared,
node A has either two or four numerical values: If the
data consist of a single measurement, for node A these
are the two values MA
E1 , MA
E2 . If replicates are analyzed,
the two values MA
E1 , MA
E2 are the mean values and the
two variances VarA
E1 , VarA
E2 are also provided. The
number of replicates are n1 and n2. ExprEssence analyses
based on replicated measurements, where mean values
and variances are used as input, are more reliable than
analyses based on single measurements. Specifically, as
the variances are used for calculations, feature variation
within and between groups is considered and evaluated
appropriately. However, also comparisons based on sin-
gle measurements can be used to suggest underlying
mechanisms.
Identifying change in a network, motivation
F o re a c hl i n ki nt h en e t w o r kw ew a n tt om e a s u r et h e
amount of change between experiments E1 and E2,
where ‘change’ is a modification in the intensity with
which one gene/protein may be influencing another
gene/protein; depending on the input data, such influ-
ence may be direct physical interaction (in the case of
proteins), transcriptional stimulation or inhibition.
Therefore, for all links connecting two genes/proteins A
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uses the measurements MA
E1 , MA
E2 and MB
E1 , MB
E2 for
the two experiments E1 and E2 to calculate a link score
proportional to the amount of change from E1 to E2.
The formulae are given in the next section. The sign of
the score corresponds to the direction of change giving
ap o s i t i v es c o r ef o rs t a r t u p sa n dan e g a t i v es c o r ef o r
shutdowns. The magnitude of this signed change corre-
sponds to the absolute value of the score. Links with a
link score whose absolute value does not exceed a user-
defined threshold are deleted from the network. Hence,
only those links are kept, where changes (startups or
shutdowns) are pronounced.
Following the heatmap metaphor, large measurement
values for genes are indicated by red color and small
values are indicated by green color. Similarly, links with
ap o s i t i v ev a l u eo ft h el i n ks c o r ea r ec o l o r e di nr e da n d
indicate startups. Links with a negative value are colored
in green and indicate shutdowns.
More specifically, in case of a stimulation of gene/pro-
tein T (target) by gene/protein S (stimulator), abbreviated
S ® T , we suppose that the stimulation starts up (from
E1 to E2), if the values of both genes increase (see Figure 1
(a) and Figure 2(a); values for both genes S and T go up,
green to red). If the values of both genes decrease, we sup-
pose that the stimulation shuts down (Figure 1(b) and Fig-
ure 2(b)). In short, we reward correlated change. In case of
an inhibition of gene/protein T (target) by gene/protein I
(inhibitor), abbreviated I ® T , we suppose that the
inhibition starts up (from E1 to E2), if the value of the inhi-
bitor increases from E1 to E2, and the value of the target
goes down (Figure 2(c)). If the value of the inhibitor
decreases from E1 to E2, and the value of the target goes
up, we suppose that the inhibition is shut down (Figure 2
(d)). In short, we reward anti-correlated change.O t h e r
cases, such as no change of values or an inconsistent
change, that is an anticorrelated change in case of a stimu-
lation or a correlated change in case of an inhibition, give
rise to a link score with a reduced absolute value, see Fig-
ure 1(c) and 1(d), Figure 2(e)-(m), and below.
Note that stimulations are treated in a symmetrical
way: S ® T is treated the same way as T ® S. Indeed, we
do not and cannot distinguish S ® T and T ® S, because
in both cases we expect increments in S to be correlated
with increments in T : Higher amounts of the stimulator
go hand in hand with higher amounts of the target. A
similar argument holds for decrements. Motivated by this
argument, interaction links (S ↔ T ) are treated in the
same way as stimulation links. This makes sense in gen-
eral, because the amount of A and B interacting with
each other increases in proportion to the amount of both
interactors. More generally, if the interaction represents a
biochemical reaction, a straightforward interpretation of
our reasoning is given by the law of mass action, see the
next section ‘Calculation of the amount of change’.
Calculation of the amount of change
Recall that for measurements of two experiments E1 and
E2, and two genes/proteins A and B,w ed e n o t et h e
mean of the measured values for A, or, if only data of
one measurement exists, the single value for A in
experiment E1 by MA
E1 , and in experiment E2 by MA
E2 ,
respectively. The values for B are MB
E1 and MB
E2 .W e
can then calculate the amount of change as described in
the following. For gene/protein A, we determine the dif-
ferential of A, DA, that is the difference of the measured
values between experiments E1 and E2:
DM M A A
E
A
E =− 21 . (1)
In case of replicates, DA is corrected for the variance
within the replicates for both experimental conditions,
employing Welch’s formula [37]:
D
MM
Var
n
Var
n
A
A
E
A
E
A
E
A
E =
−
+
21
12
12
,
(2)
where MA
E1 , MA
E1 : Mean value of gene/protein A
under experimental condition E1, E2;
Figure 1 Network condensation - exemplified for stimulations.
For each of the panels (a) to (d), in the graphs on the left side a
stimulator (S) and a target (T) are connected by a stimulation link.
Values in the first (E1, upper graph) and second experiment (E2,
lower graph) are indicated, where low values are marked green and
high values are red (following the heat map metaphor). The
coloring scheme is red, pale red, white, pale green and green, in
order of decreasing values (see text). The graphs on the right side of
each panel show the resulting link after applying our method. For
each gene, its values for E1 and E2 are now inlineed simultaneously
in the circle (value of E1 on the left, of E2 on the right side). The link
connecting both nodes describes the direction and the amount of
change between E1 and E2. Links with startup of stimulation are
colored in red (a), shutdown links in green (b). If values do not
change for both the source and the target, or if they change in a
completely inconsistent way, the link is removed, see (c) and (d).
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E1 , VarA
E1 :V a r i a n c eo fv a l u e so fg e n eA under
experimental condition E1, E2;
n1, n2: Number of replicates done in experiment E1,
E2.
DB is determined analogously. This equation corre-
sponds to the Welch t-test for comparison of mean
values of two samples with unequal variances. As we do
not want to make strong preconditions about the statis-
tical distribution of the samples, we do not calculate
p-values. The weaker preconditions for Welsh’st - t e s t
are fulfilled if, for both experiments, independent sam-
ples are measured, and if their values are approximately
normally distributed. Given DA and DB, the amount of
change for an interaction link is the sum of the two dif-
ferentials:
LinkScoreInt A B DD =+ . (3)
Taking the difference MM A
E
A
E 21 − and not
MM A
E
A
E 12 − reflects the motivation to denote startups of
interactions by a positive score and shutdowns by a
negative score.
The formula gives scores with high absolute value for
correlated changes of the values of A and B from E1 to
E2. Depending on the direction of the correlated change,
the score becomes positive or negative which denotes a
startup or shutdown of the interaction/stimulation.
Anti-correlated changes are given a reduced absolute
v a l u eo ft h es c o r e( s e eb e l o wa n dF i g u r e2 ( f )a n d2 ( h ) ) .
The formula is simple, yet powerful:
1. In the specific case of a physical interaction
between two proteins, and log-transformed data, the
formula above corresponds to the law of mass
action, as follows. The ‘activity’ of a physical interac-
tion of protein A with protein B can be expressed by
the product of the abundances of both, assuming
that the expression values correspond to the
‘amount’ of protein. The ‘amount’ of the complex
AB in experiment 1 can then be compared to the
‘amount’ of the complex AB in experiment 2, by tak-
ing the ratio. Large changes in this ratio indicate
that there will be much more or much less of the
protein complex, comparing experiment 1 with
experiment 2. (Note that we do neither calculate
Figure 2 Network condensation - a gallery of various scenarios. For each gene, its (expression) values are represented by color. For each
link, its score is represented by color and thickness. The coloring scheme is red, pale red, white, pale green and green, in order of decreasing
values (see text). Links connecting genes with measurement values changing in an inconsistent way are marked by wavy lines. As in Fig. 1, if the
interacting genes are linked by a stimulation S ® T , the stimulation is assumed to start up, if for both genes, the values go up from E1 to E2
((a), E1 value: left side of circle, E2: right side of circle), and it is assumed to be shut down if both values go down (b). An inhibition I ⊣ T is
assumed to start up, if the inhibitor value goes up, but the target value goes down (c); it is assumed to shut down if the inhibitor value goes
down and the target value goes up (d). In cases (e) and (f) the startup of the stimulation as presented is still a justified hypothesis, even though
the target does not go up. For example, in (e) and (f), the stimulation by the source (the stimulator) goes up but it may be counteracted by
other inhibiting effects (dashed T-Bar arrow) on the target, as the target does not change (e) or even goes down slightly (f) (source principle, see
text). In cases where the amount of the stimulator is constant (g) or goes down slightly (h), the startup of a stimulation is still a justified
hypothesis based on the target value. Strictly speaking, we hypothesize the startup of the stimulatory effect on the target gene. For example, in
(g), the startup is not concluded from the change in the value of the stimulator, but it may be due to stimulator accumulation in time, and/or
due to cooperation of the stimulator with other stimulations of the target which go up at the same time; startup of the stimulating effect is
concluded from the behaviour of the target (target principle, see text). Scenario (i) is another example of the source principle: it is a justified
hypothesis that the inhibition starts up because the amount of inhibitor increases, even though counteracting stimulations drive the amount of
the target. Scenario (k) is another example of the target principle: it is a justified hypothesis that the stimulatory effect goes up, observing the
target and assuming other cooperating effects on it. Lastly, if values do not change at all, or if they change in a completely inconsistent way,
the amount of change is zero or near to zero, as in (l) and (m) (also see Fig. 1 (c) and (d)). Note that cases (e)-(m) all result in reduced link scores.
Hence, inconsistent links tend to be removed from the network, as the link score threshold is made more stringent.
Warsow et al. BMC Systems Biology 2010, 4:164
http://www.biomedcentral.com/1752-0509/4/164
Page 5 of 18equilibrium constants nor reaction kinetics.) As we
have two experimental conditions and are interested
i nt h ec h a n g ef r o mE1 to E2,s t a r t u po f‘activity’ is
thus proportional to the ratio of the products of the
abundances of A and B, taking experiment E2 over
experiment E1: ([ ] [ ] ) /([ ] [ ] ) AB AB
EE EE 22 11 ⋅⋅ .I n
case of log-transformed values, this is the difference
of the sums of the measurement values under both
conditions: () () MM MM A
E
B
E
A
E
B
E 22 11 +−+.T h i sc a n
be written as () () MM MM A
E
A
E
B
E
B
E 21 21 −+− and cor-
responds to DA + DB from formula (3). Hence, our
formula for the link score of interaction links can be
connected directly to the law of mass action.
2. As explained above, we can treat the stimulation
of a gene/protein A by a gene/protein B in the same
way as an interaction of the two proteins with each
other and therefore use the same formula to deter-
mine the link score:
LinkScore LinkScore Stim Int A B DD == + . (4)
3 .F o r m u l a( 4 )c a nb em o d i f i e dt oc a p t u r ei n h i b i -
tions A ® B (A inhibits B), where A and B are
expected to be anticorrelated in their expression/
amount:
LinkScoreInh A B DD =− . (5)
This equation honors the case where higher
amounts of the inhibitor A go hand in hand with
lower amounts of the target B and vice versa,
whereas correlated changes are penalized (see Figure
2(c) and 2(d)).
4. Our formulae deliver justified hypotheses also
in the cases that are not as straightforward as the
cases in Figure 1(a)-(b)/Figure 2(a)-(d), given two
additional assumptions, that we call the source
principle and the target principle. It is important
to note that these complicated cases are character-
ized by relatively low link scores and additionally
they will be marked by wavy lines. Furthermore,
they can be identified by inspecting the color-
coded measurement values (Figure 2(e)-(k)), which
can be made explicit by addition of gene/node
labels as in the condensed networks of case stu-
dies 2 and 3.
The source principle maintains that changes in the
source, if they are large enough, are sufficient for a
hypothesis regarding startup/shutdown of a stimula-
tion/inhibition. Even if the value of the target is
inconsistent, putting trust into the network data
(that is, the stimulation/inhibition link is not ques-
tioned), the link then describes a startup/shutdown
which is assumed to act on the target, even though
it is counteracted by other effectors (Figure 2(e),(f),
(i)). The other effectors may or may not be included
in the network: we assume that the network is cor-
rect, but not necessarily complete. In case of tran-
scriptional stimulations/inhibitions, a simple
example for counteracting effectors are transcription
factors that act in an opposite way at a different
position of the regulatory region of the target gene.
Here, we view gene regulation as a ‘transcription fac-
tor battlefield’ [38,39]. In fact, the target gene may
not be observable (expressed) at all without the sti-
mulation that is highlighted. There is alternative
interpretation for an inconsistent target value: The
stimulation may not be in the scope of what is being
measured. For example, if the values refer to expres-
sion levels, a stimulation of the target by phosphory-
lation goes undetected.
The target principle holds that large changes in the
target are sucient for a hypothesis regarding startup/
shutdown of a stimulation/inhibition, even if the
value of the source (the stimulator/inhibitor) is
inconsistent. Again trusting the network data, the
link then describes a startup/shutdown that is
becoming relevant because other effectors are now
cooperating on the target (Figure 2(g),(h),(k)). Then,
strictly speaking, in all these three cases we hypothe-
size that it is not the stimulation itself that goes up,
but its effect on the target gene. Again, we view
gene regulation as a ‘transcription factor battlefield’.
Also, the other effectors may or may not be part of
the network. Of course, the inconsistent change in
the source has to be lower than the tale-telling
change in the target. Also, the startup of the stimu-
lating effect is assumed to require only a low
amount of the stimulator, which is however still
exceeded. There is an alternative interpretation for
an inconsistent source value: The stimulating effect
may simply be delayed in case of a time series,
where the stimulator (protein) needs time to accu-
mulate, which may also happen during a period of
constant or down-regulated gene expression of the
stimulator.
Naturally, inconsistencies can also give rise to revi-
sion of the network. However, our formula is not
designed to reveal severe inconsistencies (since such
links receive scores close to zero and are removed
from the network as in Figure 2(m)).
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cases by inspection, and to aid the interpretation of
links, our plugin offers multi-colored nodes, inline-
ing directly the measurement values of a gene for a
pair of experiments within a single node as a pie-
chart as explained in Figure 1 and inlineed in Figure
2. To calculate the color for visualization of the
values in the pie-chart, we take the 10%, 50% and
90% quantiles of the ordered list of all attribute
values. The value associated with the 10% quantile
defines the lower threshold. All values below this
threshold are visualized by green color of same
intensity. Values above this threshold and up to the
value corresponding to the 50% quantile get a color
defined by linear interpolation between the 10%
quantile (green color) and the 50% quantile (white).
Analogously, values are visualized by a color
between white (50% quantile) and red (90% quan-
tile). Values above the 90% quantile are represented
by red color of same intensity. The thresholds and
the coloring scheme can be redefined by the user.
Furthermore, our plugin provides labeling of selected
genes/nodes with the measurement data used for
node coloring as shown in the condensed networks
of case studies 2 and 3.
Finally, depending on the value of the Interactiontype
a t t r i b u t ef o ral i n k ,t h er e s p e c t i v ef o r m u l af o rt h el i n k
score is as follows:
LinkScore
Interactiontype Interaction Int
=
= LinkScore if
LinkSc
,
o ore if
LinkScore if
Stim
Inh
Interactiontype stimulation
Intera
= ,
c ctiontype inhibition =
⎧
⎨
⎪
⎩
⎪ .
(6)
We will use this link score to identify those links
along which there is a large change between E1 and E2.
Links with a link score exceeding a user-defined thresh-
old are colored in red or green; the other links are
deleted from the network.
Condensation of networks
After importing the network and measurement data into
Cytoscape, the ExprEssence dialog window is used to
define which data shall be taken for calculation of the
link score and hence for network condensation. As dis-
cussed above, the network must include at least two
numerical attributes for each gene/protein, so that the
formulae can be employed. These two attributes are
explicitly selected by the user, indicating their order (E1
versus E2,o rE2 versus E1). After selecting two attri-
butes, the user may then indicate that there is variance
data available and specify the number of replicates. In
this case, the measured values are implicitly assumed to
be the mean values for which the variances are
provided. Finally, calculations are started and results are
inlineed in a new network window in Cytoscape. Links
w i t hap o s i t i v ec h a n g e( s t a r t u p s )a r er e n d e r e di nr e d ,
and negative change (shutdown) is rendered in green.
Color saturation and link thickness are directly linked to
the link score calculated.
In the user control interface of ExprEssence,as l i d e r
(Figure 3) is provided to define the threshold to keep all
links with link score exceeding the threshold, on both
the positive (startup) and negative (shutdown) side of
the spectrum of link score values. Using this slider, the
user can cut the number of links in the network. The
more stringent the threshold, the more links are
removed and only links with high absolute value of the
link score will remain. Genes which have no link left
after removal of links are also removed from the net-
work. Using the condensed network, the user can inves-
tigate components of the network where interactions,
stimulations or inhibitions start up or shut down, com-
paring experiment E1 with E2.
Results
We present results of the application of ExprEssence in
three case studies.
Case Studies
We will describe three application scenarios, condensing
networks and describing the insights gained from these.
As a first example, we condense a network based on lit-
erature-curated interaction data of proteins involved in
structure and function of the podocyte, which is the cell
forming the kidney filtration barrier. The second exam-
ple will describe how a hand-curated network of interac-
tion and regulation of genes maintaining the pluripotent
state of stem cells can be condensed using microarray
data tracking an early transition process of embryonic
stem cells, yielding a mechanistic hypothesis that was
then confirmed experimentally. In a third application,
we will take a biological network describing ageing-
related processes from the WikiPathways database, inte-
grate publicly available microarray data, and confirm
some basic insights into ageing. Cytoscape session files
PodocyteCellMatrix.cys, Epiblast.cys and DNA_Damage.
cys are provided as Additional Files 1, 2 and 3, and they
enable reproduction of figures following the instructions
given there.
Case Study 1 - Interaction network of podocyte cell-matrix
proteins
Podocytes cover the outer aspect of the capillaries in the
kidney glomerulus, where the ultra filtration of blood
takes place. The filtration barrier is composed of
endothelial cells, the glomerular basement membrane
(GBM) and podocytes. The proper function of podo-
cytes is essential for the ultrafiltration process.
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Page 7 of 18Podocytes synthesize the majority of extracellular matrix
molecules that are present in the GBM. The podocyte-
GBM interface is crucial for mechanical anchorage and
inside-out as well as outside-in signaling. Damage or
loss of podocytes is estimated to be responsible for
about 90% of kidney diseases in humans [40]. To date
several hereditary kidney diseases are known that are
caused by mutations in genes involved in the podocyte-
GBM interface, e.g. Alport syndrome. Thus, the podo-
cyte-GBM interface is of central importance in kidney
biology and pathology.
We constructed a protein interaction network of the
podocyte-GBM interface based on expert knowledge.
We collected proteins and experimentally well-described
protein-protein interactions of the podocyte-GBM inter-
face by a comprehensive survey of the podocyte literature.
The expert network consists of 42 nodes (proteins) and 33
edges (protein-protein interactions). The proteins of the
expert network were screened for further interaction part-
ners utilizing the STRING database [11], to extend the
expert network by further experimentally verified interac-
tions involving at least one node (protein) of the network.
If not yet existent in the network, the respective interac-
tion partners were also added. The extended network
consists of 124 nodes and 206 edges (Figure 4).
Podocyte cell lines are a frequently employed tool to
study podocyte biology. However, it is well known that
podocyte cell lines are partially dedifferentiated as com-
pared to in vivo podocytes. To extract the main differ-
ences between the podocyte-GBM interface of in vivo
vs. cultured podocytes, we mapped microarray gene
expression data of in vivo and cultured mouse podo-
cytes onto the extended network shown in Figure 4. We
used publicly available microarray data (GSE10017, [41])
generated from a podocyte cell line and from in vivo
podocytes, which were isolated as podocalyxin-positive
cells in a cell suspension of enzymatically digested
m o u s eg l o m e r u l i .B yc o n d e n s ing a protein interaction
network using gene expression data, we implicitly
assume that protein abundance is correlated to gene
expression. We log-transformed and quantile-normal-
ized these data.
By interactive use of ExprEssence we removed 94% of
the edges keeping the 3% quantiles of the most strongly
differentially altered interactions between in vivo and
cultured podocytes (Figure 5). ExprEssence revealed that
the interactions of semaphorin 3 d (Sema3d), fibroblast
growth factor receptor 1 (Fgfr1) and Gipc1 PDZ
domain-containing protein (Gipc1) with neuropilin
1 (Nrp1) as well as the interaction between pinch
2 (Lims2) and a-parvin (Parva) are most strongly dimin-
ished (green links) in cultured podocytes as compared
to the in vivo situation. On the other hand, the interac-
tions of integrin b3 (Itgb3) and myelin-associated
Figure 3 Slider in the ExprEssence user interface. Thresholds may
be set independently for both the upper (red arrow) and the lower
(green arrow) side of the spectrum of the link scores.
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Page 8 of 18glycoprotein (Mag) with fibronectin 1 (Fn1) are most
strongly up-regulated in cultured podocytes. As Mag
had so far not been reported as a podocyte protein, we
analyzed Mag expression by RT-PCR in a podocyte cell
line. Indeed, Mag expression was easily detected in cul-
tured podocytes (Figure 6), revealing a novel candidate
for the podocyte-GBM interface.
Podocytes dedifferentiate under cell culture condi-
tions. Dedifferentiation of podocytes in culture may
recapitulate dedifferentiation of podocytes in vivo during
kidney disease. Thus, comparing gene expression
between cultured and in vivo podocytes may give impor-
tant clues about essential proteins and protein interac-
tions needed for proper podocyte function. ExprEssence
segregates the most strongly differentially altered inter-
actions between cultured and in vivo podocytes, corro-
borating previous findings and discovering novel protein
interactions that might be involved in the podocyte-
GBM interface:
1. Pinch and parvin participate in integrin signaling
via integrin-linked kinase. This pathway is essential
for podocyte function, since mice with podocyte-
specific knockout of integrin-linked kinase die from
renal failure at the age of 16 weeks [42]. The pinch/
parvin interaction is shut down in cultured podo-
cytes (see Figure 5), making it a candidate key inter-
action reflecting podocyte dedifferentiation in cell
culture. In the healthy kidney, pinch and parvin may
have an important role in transmitting signals from
the extracellular matrix through integrin-linked
k i n a s e ,t om a i n t a i np o d o cytes in a differentiated
state [43].
2. Neuropilin and its interaction with the guidance
molecule semaphorin have been implicated in podo-
cyte differentiation [44,45]. The interaction of neuro-
pilin with several proteins, including semaphorin, is
greatly diminished in cultured podocytes (see Figure
5). ExprEssence uncovers that loss of neuropilin
interaction with extracellular molecules also partici-
pates in the dedifferentiation of podocytes in culture
as suggested by the in vivo findings [46].
3 .M a s s i v eu p - r e g u l a t i o ni nc u l t u r e d( =d e d i f f e r e n -
tiating) podocytes of the interaction between fibro-
nectin 1 and the membrane protein Mag, suggest an
important and hitherto unknown function of Mag in
Figure 4 Protein interaction network of the podocyte GBM-interface (STRING-extended expert network).
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Page 9 of 18the regulation of podocyte differentiation through
the podocyte-GBM interface. Indeed, we could con-
firm podocyte expression of myelin-associated glyco-
protein (Mag) (Figure 6), which has so far not been
implicated in podocyte biology. Since myelin pro-
teins are known to be expressed only in glial cells of
the nervous system, it is also notable that knockout
of myelin protein zero, another myelin protein pre-
ferentially expressed in podocytes within the glomer-
ulus, has been shown to result in proteinuria [47].
Case Study 2 - Analysis of a pluripotency-related
experiment
Stem cell research is currently one of the most active
areas in molecular biology and biomedicine, based in
part on recent breakthroughs in generating ‘induced
pluripotent stem cells’ (iPS cells) from somatic cells like
fibroblasts (reviewed in [48,49]). Such a ‘reprogramming’
of differentiated cells into ‘pluripotent’ ones is possible
by directly manipulating gene regulation in the cell, con-
fronting the differentiated cell with artificial amounts of
key transcription factors such as Oct4 (also known as
POU5F1), Sox2 and Nanog. These ‘ectopic’ factors then
re-direct the overall network of interaction and regula-
tion into a direction that is so close to the ‘embryonic
state’ that mice can be obtained, in which some (or even
all) of their cells derive from the manipulated somatic
cells [50]. A mouse suering from sickle-cell anemia was
healed by reprogramming fibroblasts from its tail, cor-
recting the genetic defect, and re-differentiating the iPS
cells into blood-building cells that were then injected
[51]. In human, iPS technology already allows to study a
patient-specific disease in the ‘petridish’, and to regene-
nerate tissues by re-differentiating iPS cells. Safety con-
cerns currently hinder the engraftment of ‘healed’ tissue,
and triggering the re-direction of the regulatory network
by chemical compounds is one avenue to improve
safety. Consequently, molecular analyses of the induc-
tion of pluripotency and of (re-)differention triggered by
small chemical compounds is of high interest in the
human as well as in the mouse system. Over the past
year, we have assembled a network of molecular interac-
tions, stimulations and inhibitions from 135 publications
until March 2010, involving 262 genes/proteins of
mouse. The network includes the core circuit of Oct4,
Sox2 and Nanog, its periphery (such as Klf4, Esrrb, and
c-myc), connections to upstream signaling pathways
( s u c ha sA c t i v i n ,W n t ,F g f ,B m p ,I n s u l i n ,N o t c ha n d
LIF), and epigenetic regulators (Figure 7). An updated
(June 2010) version of this ‘PluriNetWork’ is described
in [14].
Applying ExprEssence to our expert network, we ana-
lyzed recently published data (GSE17136 [52]) on the
effect of a pharmacological inhibitor (JAKi, Janus kinase
Inhibitor I, Merck) on embryonic stem cells, which trig-
gers a transition process from the embryonic stem cell
Figure 5 Condensed network resulting from the application of
ExprEssence to the network in Fig. 4, using gene expression
data from in vivo (left side) and cultured podocytes (right side).
Only links with highest and lowest link score were kept (3%
quantile on both sides).
Figure 6 Podocyte RT-PCR expression analysis of Mag.M o u s e
kidney and two mouse podocyte cell lines (K5 D and S6) were
cultured as reported earlier [63]. Podocyte RNA was isolated using a
mixture of guanidine thiocyanate and phenol (TRI Reagent, Sigma)
according to the manufacturer’s protocol. Reverse transcription was
performed on 5 μg denaturated RNA. Real-time PCR was performed
with a Light Cycler (Roche Diagnostics, Mannheim, Germany) using
the Platinum® SYBR® Green qPCR SuperMix-UDG kit (Invitrogen,
Heidelberg, Germany) and run at 95°C for 10 min followed by 45
cycles at 95°C for 10 s, 60°C for 5 s, and 72°C for 12 s. Relative
expression was normalized using GAPDH. The following primers
were used: Mag sense 5’-TGG GCC TAC GAA ACT GTA CC-3’, anti-
sense: 5’-GCT CCG AGA AGG TGT ACT GG-3’, 110 bp expected
product size; Gapdh sense 5’-ACC CAG AAG ACT GTG GAT GG-3’,
antisense 5’-CAC ATT GGG GGT AGG AAC AC-3’, 170 bp expected
product size. A 50 bp DNA step ladder was loaded in the left lanes.
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Page 10 of 18to another pluripotent cell state, the epiblast stem cell
state. The effect is described by microarrays taken
before, and 12 hours after the intervention. We kept
the 5% quantiles of links with the largest amount of
change. We observed that shutdown of stimulations is
centered around the protein Esrrb, the expression of
which is just slightly diminished (see Figure 8). Coop-
erative Esrrb regulation by a variety of transcription
factors such as Klf4, Klf2 and Klf5 has already been
observed by Jiang et al. [ 5 3 ] .T h u s ,w ep r e d i c tE s r r b
down-regulation at a later time point. More specifi-
cally, Figure 8 inlines the condensed expert network,
describing the effects of inhibition of the LIF/Jak/Stat3
signaling pathway [52] by the JAK inhibitor I. Notably,
the stimulations of Esrrb by Nanog [54], Klf2, Klf4,
Klf5 [53] and by itself [55] are shut down. These
shutdowns are the result of down-regulation of these
stimulators within the first 12 hours. Klf2, Klf4, Klf5
and Nanog are known to be upstream of the ES cell-
specific transcription factor Esrrb [53,55,56]. However,
a strong effect on Esrrb was not yet seen at the 12
hour time-point, but according to Figure 8 our model
suggested a down-regulation of Esrrb as a consequence
of JAK inhibitor-mediated down-regulation of its
upstream factors. To test this hypothesis, we carried
out real-time PCR analysis of JAKi-treated ES cells at a
later time-point, 48 hours. As can be inferred from
F i g u r e9K l f 4w a sa l r e a d yd o w n - r e g u l a t e da t1 2h o u r s
but its downstream target gene Esrrb was not. At 48
hours, however, we did observe significant down-regu-
lation of Esrrb, confirming the idea of its shutdown via
other members of the ES cell self-renewal network.
Figure 7 A network describing pluripotency-related interaction and regulation data assembled from the literature. The core part
describes gene regulation, the upper part signaling pathways, and the part on the left epigenetic phenomena.
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Page 11 of 18As Klf4 and Nanog are known to be stimulated by
Esrrb [55,56], these stimulations are also shut down
(Figure 8target principle). Finally, interactions between
the transcription factors Stat3, Hdac1, c-Myc & Nanog
and Trim28 (also known as TIF1b,at r a n s c r i p t i o nc o -
regulator (co-repressor) and chromatin modifier [57,58])
are started. These startups are highlighted because the
Trim28 expression value goes up strongly, from 7041 to
9124. The role of these startups is unknown, though
they may reflect the general repression of components
of the ES cell-specific self-renewal network by Trim28.
Case Study 3 - Analysis of ageing-related experiments
To study the effects of ageing on DNA damage
response, we retrieved a network from WikiPathways
[31], ‘DNA damage response’ in human, as of May 22,
2010. After importing it to Cytoscape, we expanded all
complexes yielding the network in Figure 10. For exam-
ple, for a complex in the original network such as
CDK2, CCNE1 and CCNE2, all genes were connected
pairwise to each other. We then integrated log-trans-
formed and quantile normalized microarray data from
GSE11882 [59]. From this dataset we used only the data
Figure 8 Network of protein interactions and gene/protein stimulations and inhibitions involved in pluripotency, condensed using
ExprEssence and microarray data tracking the transition process from embryonic stem to epiblast-like cell state. Expression values for
Trim28, Esrrb, Klf4, Klf2, Klf5 are inlineed to the left (ES state) and to the right (epiblast state) of the gene (node). Esrrb and Trim28 are both
found in the upper right corner.
Figure 9 Esrrb down-regulation is a later event in the ES-
Epiblast transition. Real-time PCR analysis of mouse embryonic
stem (ES) cells treated for 12 and 48 hr with a pharmacological
inhibitor against JAK to inhibit LIF/JAK/STAT3 signaling, which
induces a partial transition to the epiblast state. Note that the
known LIF/STAT3 target genes Socs3 and Klf4 are rapidly down-
regulated at 12 hr. At this timepoint, Esrrb expression is almost
unaffected. As suggested by the model, however, Esrrb inlines
down-regulation at 48 hr, whilst Oct4 expression is stable (the FGF/
MEK/ERK-inhibitor PD (PD0325901) was applied in all experiments).
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same four age categories (20-39, 40-59, 60-79, and 80-
99 years) as in [59]. Using ExprEssence,w ea n a l y z e dt h e
changes between the first (20-39 years) and the last age
category (80-99 years) and kept the 3% quantiles of the
most strongly differentially altered links. The startup of
the stimulation of CASP8 by FAS (Figure 11 top red
link) and the shutdown of the inhibition of CCNE1 by
CCND3 are the largest changes. The up-regulation of
apoptosis, highlighted by the red link between FAS and
CASP8 just mentioned, is the result of stimulation by
p53 (TP53), and is a known phenomenon in ageing pro-
cesses [60]. Note that the expression value of CASP8 is
going up slightly (from 4.56 to 5.38), whereas the up-
regulation of FAS is more pronounced (from 5.37 to
7.15). The down-regulation of the inhibition of CCNE1
by CCND3 [61] and CCND1 as well as by their corre-
sponding kinase CDK6 may trigger the higher expres-
sion of CCNE1, indicating a deregulation of the cell
cycle. Finally, we found ageing-related up-regulation of a
DNA repair pathway, that is, stimulation of DDB2 by
p53 [62].
Subnetwork identification by jActiveModules for Case
Studies 1-3
To put the results obtained in case studies 1-3 into the
context of related work, we used jActiveModules [15] to
analyze the same data, identifying ‘active modules’,t h a t
are subnetworks where the constituent genes show sig-
nificant changes in expression over the two conditions
we investigate. As discussed in the section on ‘Related
Work’,t h ea i mo fExprEssence is quite different, namely
the identification of single links (interactions, stimula-
tions, inhibitions) and genes affected in the course of an
experiment, where the links do not necessarily have to
build up a connected subnetwork. Furthermore, ExprEs-
sence exploits the knowledge about stimulations and
inhibitions that may be encoded in the network.
We used jActiveModules with default parameters. In
contrast to ExprEssence, which takes two expression
values per gene (one for each experimental condition),
jActiveModules requires one p-value per gene (describ-
ing the statistical significance of the expression change
between the two experimental conditions; p-values were
used as calculated while processing the raw expression
data for the case studies).
Figure 12 inlines the results of jActiveModules applied
to the data of case study 1 (podocyte cell-matrix pro-
teins). Module scores are (from left to right) 4.048,
3.384, 2.927, 2.861, 2.761. The first four subnetworks
are overlapping. The Nrp1 gene/protein that is found in
these four subnetworks is also found in our condensed
n e t w o r k( F i g u r e5 ) .I nF i g u r e1 2N r p 1i sl i n k e dt o
Sema3a & Sema3c, as well as to Fgfr1 & Sema3 d, and
Figure 10 Network adapted from the WikiPathways ‘DNA damage response’ network in human.
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cantly. Links to the latter two genes are highlighted by
ExprEssence, because change of expression is correlated
as in Figure 1(b), even though Fgfr1 & Sema3 d change
only slightly. Links to the first two genes are not high-
lighted by ExprEssence, because change of expression is
anti-correlated as in Figure 1(d), and the link threshold
is not exceeded (Figure 1(d) describes a case of perfect
anti-correlation yielding a link score of 0). Similarly, the
subnetwork Lyn-Evl-Src is not highlighted, because the
link scores are below threshold. In turn, the links
between Fn1 and Mag/Itgb3 are not picked up by
jActiveModules, because Mag/Itgb3 do not change with
sufficient significance (p-value); the same holds true for
Itga7, Parva and Itgav.
The results of jActiveModules for case study 2 (transi-
tion from the embryonic stem cell to the epiblast stem
cell state) are shown in Figure 13. Interestingly, we dis-
cover one small and two very large modules, scoring
3.612, 3.386, 2.768, respectively. The small network is
composed of Klf4 (which is also a focus of highlighting
by ExprEssence, due to its strong down-regulation) and
Arid3a, which is the protein linked to Klf4 that changes
most significantly. The two large modules have
Figure 11 Condensed network resulting from the network in Fig. 10. The genes (nodes) contain color-coded (heat map) information about
gene expression among young subjects (left side) and old subjects (right side). Expression values for FAS and CASP8 are inlineed to the left and
right of the gene (node).
Figure 12 Results of jActiveModules, default parameters, applied to the Podocyte dataset (case study 1). See also Figs. 4/5.
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Page 14 of 18significant overlap with each other, and also with the
ExprEssence-condensed network (Figure 8), but it can
immediately be seen that the latter is more informative
than the results of jActiveModules, due to link thickness
and coloring, allowing easier identification and interpre-
tation of mechanisms behind the observed expression
change.
Finally, we put together the active modules found for
the Ageing example of case study 3 (Figure 14). As in
case study 2, large overlapping networks are obtained.
Module scores are (from left to right) 1.899, 1.868,
1.387, 0.786, 0.547. The majority of the modules identi-
fied by jActiveModules include the link between TP53
and FAS, which is also highlighted by ExprEssence.T h e
link between FAS and CASP8 is only considered mar-
ginally active (it is found in one module), because
CASP8 does not feature a change with a high p-value.
The link between CCND3 and CCNE1 is not considered
by jActiveModules, because change of CCNE1 is not suf-
ficiently significant.
Overall, we observe an overlap of results between our
tool and jActiveModules. In all case studies, jActiveMo-
dules did not identify many of the links/effects on genes
that we discovered and validated. However, it identified
interesting subnetworks (around Nrp1; Klf4-Arid3a;
around TP53) that are plausible and worth investigating.
Most importantly, however, ExprEssence can distinguish
stimulations and inhibitions, and by marking links in
thick green or red color, we enable a more informed
focus on single links and genes, directly yielding sugges-
tions for experiments that may test the hypotheses we
generate.
Conclusions
The most important limitation of our approach is that
highlighting is neither necessary nor sufficient for
detecting mechanistic change. More specifically, it is
q u i t ep o s s i b l et h a tn oc h a n g e( n os t a r t u po rs h u t d o w n
of an interaction, stimulation or inhibition) happens
across a highlighted link, or that change happens across
a link that is not highlighted. The main reason for this
problem is missing accuracy (in terms of sensitivity, i.e.
false negatives, and specificity, i.e. false positives) of
both network and measured data. In particular, many
networks are seriously incomplete, so that we cannot
highlight the ‘essential’ mechanisms simply because
there are no links in the network that represent them.
For example, the main mechanism may be mediated by
Figure 13 Results of jActiveModules, default parameters, applied to the Pluripotency dataset (case study 2). See also Figs. 7/8.
Figure 14 Results of jActiveModules, default parameters, applied to the Ageing dataset (case study 3). See also Figs. 10/11.
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Page 15 of 18a regulatory RNA, which may be neither represented in
the network, nor in the expression data gained by
microarray experiments. Then, we simply cannot dis-
cover it, and the mechanisms that are highlighted will
be either minor, or simply false positive. To give another
example, imagine that the network data do not cover a
gene C that acts on both A and B, but it includes the
link A ® B. Then, the link may be highlighted even
though C is acting on both A and B, and nothing more.
Suce it to say, hypotheses generated with the help of
ExprEssence have to be validated experimentally. On the
other hand, in a signaling cascade, the mode of change
(information flow) may be via phosphorylation events
that cannot be measured by expression data. Then, A
may stimulate B via the link A ® B, but no change is
detectable in the differential expression data, and no
highlighting occurs.
With our approach towards identification of the cri-
tical parts of a gene/protein network using differential
data, we offer a means to easily become aware of
changes in gene/protein relationships that can be
observed by contrasting two experimental conditions.
We do not only consider physical interactions between
proteins but are able to take into account stimulations
or inhibitions and treat them accordingly in order to
get specific insights into regulatory aspects. ExprEs-
sence identifies startup/shutdown along all three differ-
ent link types (interaction, stimulation, inhibition) in a
coherent manner. Our method does not depend on a
specific type of network or experimental data as long
as edges in the network connect entities influencing
each other and the experimental data can be inter-
preted as measurements proportional to the abundance
of the entities.
The statistical basis for comparison of link scores of
different edges depends on the input data: if no repli-
cates are available, the plugin works without any mea-
surement of variability, and allows exploration of the
dataset. If replicates are given, the plugin uses Welch’s
formula to improve comparability of link scores by con-
sidering the variability of the measurements.
Despite its limitations, we developed a simple,
straightforward and easy-to-use tool for hypothesis
building, towards a mechanistic interpretation of experi-
ments, seeing the forest for the trees in a large amount
of data.
Additional Files
PodocyteCellMatrix.cys, Epiblast.cys, DNA_Damage.
cys. Cytoscape Session files containing the original net-
work, expression data and condensed network from case
studies 1-3.
Additional material
Additional file 1: PodocyteCellMatrix.cys. To reproduce Figure 5 open
the file ‘PodocyteCellMatrix.cys’ in Cytoscape, select the uncondensed
network, start condense!, select ‘Shaw_Ensembl’ (left side) and
‘Mundel_Ensembl’ (right side) and No variance data. After submitting,
click on Organic Layout.
Additional file 2: Epiblast.cys. To reproduce Figure 8 open the file
‘Epiblast.cys’ in Cytoscape, select the uncondensed network, start
condense!, select ‘12 h PD+LIF Signal’ (left side) and ‘12 h PD+JAKi Signal’
(right side) and No variance data. Modify the position of the two sliders
to select the 5% and 95% quantiles, and choose Organic layout.
Additional file 3: DNA_Damage.cys. To reproduce Figure 11 open the
file ‘DNA_Damage.cys’ in Cytoscape, select the uncondensed network,
start condense!, select ‘HC 1 mean’ (left side) and ‘HC_4_mean’ (right
side) and, as variance data, select ‘HC_1_var’ (left side) and ‘HC_4_var’
(right side). The number of replicates is 10 (left side) and 16 (right side).
After submitting, click on Organic Layout.
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